Disease stability over 5 years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication
Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Jack D, Vermersch P (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Abstract
What is this summary about?
Involved external institutions
Queen Mary, University of London
United Kingdom (GB)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
University of Miami
United States (USA) (US)
Medical Park AG
Germany (DE)
EMD Serono
United States (USA) (US)
Merck KGaA
Germany (DE)
LILLE 1 University - Science and Technology
France (FR)
United Kingdom (GB)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
University of Miami
United States (USA) (US)
Medical Park AG
Germany (DE)
EMD Serono
United States (USA) (US)
Merck KGaA
Germany (DE)
LILLE 1 University - Science and Technology
France (FR)
How to cite
APA:
Giovannoni, G., Comi, G., Rammohan, K., Rieckmann, P., Dangond, F., Jack, D., & Vermersch, P. (2022). Disease stability over 5 years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication. Neurodegenerative Disease Management. https://dx.doi.org/10.2217/nmt-2022-0018
MLA:
Giovannoni, Gavin, et al. "Disease stability over 5 years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication." Neurodegenerative Disease Management (2022).
BibTeX: Download